Capital & FinanceEvent: September 7, 2026
HQ Science reports that BioNTech stopped its own trial nine days later.
Published
Signal category
Capital & Finance
Quote
“Nine days later, BioNTech stopped its own trial.”
— Alex Diatlov|HQ Science team
Company
HQ Science
Get molecular diagnostics within hours, not weeks
- Industry
- Medical and Diagnostic Laboratories
- Location
- Chilton, GB
- Company size
- 8 employees
HQ Science is an Oxford-based MedTech company backed by the UK Health Security Agency, developing a point-of-care molecular diagnostics platform that delivers results in hours instead of weeks. By combining real-time transcriptomic analysis with scalable AI-driven diagnostics, we are enabling faster, more accessible precision medicine across oncology, sepsis, and emergency care, in partnership with leading institutions including the NHS, Oslo University Hospital, and the Oscar Lambret Centre.
Founded 2018